scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1052953366 |
P356 | DOI | 10.1038/SJ.BMT.1704676 |
P698 | PubMed publication ID | 15354207 |
P50 | author | Andrew L. Kung | Q38544548 |
Jean-Pierre Bourquin | Q58316774 | ||
P2093 | author name string | Clark J | |
Neuberg D | |||
Lehmann L | |||
Brennan L | |||
Guinan EC | |||
Thornley I | |||
P2860 | cites work | The World Health Organization (WHO) classification of the myeloid neoplasms | Q28202501 |
United States multicenter study of arsenic trioxide in relapsed acute promyelocytic leukemia | Q28216403 | ||
The measurement of performance in childhood cancer patients | Q34050319 | ||
Risk-adapted treatment of acute promyelocytic leukemia with all-trans-retinoic acid and anthracycline monochemotherapy: a multicenter study by the PETHEMA group | Q34542746 | ||
Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia | Q44237334 | ||
Use of arsenic trioxide (As2O3) in the treatment of patients with acute promyelocytic leukemia: the M. D. Anderson experience | Q44415297 | ||
Acyclovir for prevention of cytomegalovirus infection and disease after allogeneic marrow transplantation | Q44799887 | ||
Marked improvements in outcome with chemotherapy alone in paediatric acute myeloid leukemia: results of the United Kingdom Medical Research Council's 10th AML trial. MRC Childhood Leukaemia Working Party. | Q54531264 | ||
Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. | Q54684597 | ||
Cyclosporine, methotrexate, and prednisone compared with cyclosporine and prednisone for prophylaxis of acute graft-versus-host disease | Q70513224 | ||
A comparison of allogeneic bone marrow transplantation, autologous bone marrow transplantation, and aggressive chemotherapy in children with acute myeloid leukemia in remission | Q73335918 | ||
IBMTR Severity Index for grading acute graft-versus-host disease: retrospective comparison with Glucksberg grade | Q73497705 | ||
Treatment of relapsing acute promyelocytic leukemia by all-trans retinoic acid therapy followed by timed sequential chemotherapy and stem cell transplantation. APL Study Group. Acute promyelocytic leukemia | Q73922262 | ||
Allogeneic stem cell transplantation for advanced acute promyelocytic leukemia: results in patients treated in second molecular remission or with molecularly persistent disease | Q79087940 | ||
P433 | issue | 9 | |
P921 | main subject | acute promyelocytic leukemia | Q612108 |
stem cell transplantation | Q65592366 | ||
P304 | page(s) | 795-798 | |
P577 | publication date | 2004-11-01 | |
P1433 | published in | Bone Marrow Transplantation | Q4941523 |
P1476 | title | Favorable outcome of allogeneic hematopoietic stem cell transplantation for relapsed or refractory acute promyelocytic leukemia in childhood | |
P478 | volume | 34 |
Q27009433 | Acute Promyelocytic Leukemia (APL): Comparison Between Children and Adults |
Q35231673 | Global characteristics of childhood acute promyelocytic leukemia |
Q37485826 | Hematopoietic stem cell transplant for pediatric acute promyelocytic leukemia |
Q36380188 | Immunotherapy following hematopoietic stem cell transplantation: potential for synergistic effects |
Q36729327 | Same sibling marrow following cord allogeneic transplantation as therapy for second relapse acute promyelocytic leukemia in a pediatric patient |
Q37388701 | Treatment outcomes in relapsed acute promyelocytic leukemia patients initially treated with all-trans retinoic acid and arsenic compound-based combined therapies |
Search more.